Glucose-Induced Regulation of COX-2 Expression in Human Islets of Langerhans

Diabetes

Volumn 53, Issue SUPPL. 1, 2004, Pages

  Persaud, Shanta J ^a   Burns, Chris J ^a   Belin, Véronique D ^a   Jones, Peter M ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARACHIDONIC ACID; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; GLUCOSE; INTERLEUKIN 1BETA; ISOENZYME; MESSENGER RNA; PROSTANOID;

ANIMAL CELL; CONFERENCE PAPER; CYTOKINE PRODUCTION; EXPOSURE; GENE EXPRESSION REGULATION; GENE INDUCTION; GENE ISOLATION; HUMAN; HUMAN CELL; HYPERGLYCEMIA; INFLAMMATION; INSULIN RELEASE; LANGERHANS CELL; MOUSE; NONHUMAN; PANCREAS INSUFFICIENCY; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL;

ANIMALS; BASE SEQUENCE; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; DNA PRIMERS; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GLUCOSE; HUMANS; ISLETS OF LANGERHANS; ISOENZYMES; MEMBRANE PROTEINS; MICE; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; RNA, MESSENGER; TRANSCRIPTION, GENETIC;

EID: 0842284787     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diabetes.53.2007.s190     Document Type: Conference Paper

References (11)

1. Edelman SV, Henry RR: Insulin therapy for normalizing glycosylated haemoglobin in type II diabetes: application, benefits and risks. Diabetes Reviews 3:308-334, 1995
2. Poitout V, Robertson RP: Minireview: secondary β-cell failure in type 2 diabetes: a convergence of glucotoxicity and lipotoxicity. Endocrinology 143:339-342, 2002
3. Evans JL, Goldfine ID, Maddux BA, Grodsky GM: Are oxidative stress-activated signaling pathways mediators of insulin resistance and β-cell dysfunction? Diabetes 52:1-8, 2003
4. Maedler K, Sergeev P, Ris F, Oberholzer J, Joller-Jemelka HI, Spinas GA, Kaiser N, Halban PA, Donath MY: Glucose-induced β-cell production of IL-1β contributes to glucotoxicity in human pancreatic islets. J Clin Invest 110:851-860, 2002
5. Seibert K, Zhang Y, Leahy K, Hauser S, Masferrer J, Perkins W, Lee L, Isakson P: Pharmacological and biochemical demonstration of the role of cyclooxygenase 2 in inflammation and pain. Proc Natl Acad Sci U S A 91:12013-12017, 1994
6. Katori M, Majima M: Cyclo-oxygenase 2: its rich diversity of roles and possible application of its selective inhibitors. Inflamm Res 49:367-392, 2000
7. Sorli CH, Zhang H-J, Armstrong MB, Rajotte RV, Maclouf J, Robertson RP: Basal expression of cyclooxygenase-2 and nuclear factor-interleukin 6 are dominant and coordinately regulated by interleukin 1 in the pancreatic islet. Proc Natl Acad Sci U S A 95:1788-1793, 1998
8. Corbett JA, Kwon G, Turk J, McDaniel ML: IL-1β induced the coexpression of both nitric oxide synthase and cyclooxygenase by islets of Langerhans: activation of cyclooxygenase by nitric oxide. Biochemistry 32:13767-1377, 1993
9. Persaud SJ, Asare-Anane H, Jones PM: Insulin receptor activation inhibits insulin secretion from human islets of Langerhans. FEBS Lett 510:225-228, 2002
10. 2 in the maintenance of insulin stores, but not in the initiation of insulin secretion. Diabetes 51:98-104, 2002
11. Smith WL, DeWitt DL, Garavito RM: Cyclooxygenases: structural, cellular, and molecular biology. Annu Rev Biochem 69:145-182, 2000